Literature DB >> 20581058

Loss of estrogen receptor 1 enhances cervical cancer invasion.

Yali Zhai1, Guido T Bommer, Ying Feng, Alexandra B Wiese, Eric R Fearon, Kathleen R Cho.   

Abstract

If left untreated, some cervical high-grade squamous intraepithelial lesions will progress to invasive squamous cell carcinoma (SCC), but the molecular events conferring invasive potential remain poorly defined. In prior work, we identified 48 genes that were down-regulated in SCCs compared with high-grade squamous intraepithelial lesions and normal squamous epithelia. In this study, a functional screening strategy was used to identify which of these genes regulate cervical cancer cell invasion. Two independent squamous epithelial cell lines were transduced with a library of short hairpin RNAs targeting the differentially expressed genes and tested for invasion of the chick chorioallantoic membrane. PCR was used to recover specific short hairpin RNAs from cells that invaded the chorioallantoic membrane. Constructs targeting estrogen receptor 1 (ESR1) were highly enriched in the invasive cells. The short hairpin RNA-mediated inhibition of ESR1 in SCC- and precancer-derived cell lines increased invasiveness in both in vivo and in vitro assays. Conversely, restoration of ESR1 expression in ESR1-negative cervical cancer cells reduced cell invasiveness. Loss of ESR1 expression was found to accompany cervical cancer progression in an analysis of primary normal cervix, low grade squamous intraepithelial lesions, high-grade squamous intraepithelial lesions, and SCC specimens. Molecular mechanisms underlying down-regulation of ESR1 in invasive cervical carcinomas appear to be complex and likely heterogeneous. Our findings indicate that loss of ESR1 has a major role in mediating cervical cancer invasion and progression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20581058      PMCID: PMC2913367          DOI: 10.2353/ajpath.2010.091166

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  45 in total

1.  Detection of human papillomaviruses in cervical neoplasias using multiple sets of generic polymerase chain reaction primers.

Authors:  S Kado; Y Kawamata; Y Shino; T Kasai; K Kubota; H Iwasaki; I Fukazawa; H Takano; T Nunoyama; A Mitsuhashi; S Sekiya; H Shirasawa
Journal:  Gynecol Oncol       Date:  2001-04       Impact factor: 5.482

2.  Assessment of hypermethylated DNA in two promoter regions of the estrogen receptor alpha gene in human endometrial diseases.

Authors:  M Hori; M Iwasaki; J Shimazaki; S Inagawa; M Itabashi
Journal:  Gynecol Oncol       Date:  2000-01       Impact factor: 5.482

3.  The SLUG zinc-finger protein represses E-cadherin in breast cancer.

Authors:  Karen M Hajra; David Y-S Chen; Eric R Fearon
Journal:  Cancer Res       Date:  2002-03-15       Impact factor: 12.701

4.  MethPrimer: designing primers for methylation PCRs.

Authors:  Long-Cheng Li; Rajvir Dahiya
Journal:  Bioinformatics       Date:  2002-11       Impact factor: 6.937

5.  The polycomb group protein EZH2 is involved in progression of prostate cancer.

Authors:  Sooryanarayana Varambally; Saravana M Dhanasekaran; Ming Zhou; Terrence R Barrette; Chandan Kumar-Sinha; Martin G Sanda; Debashis Ghosh; Kenneth J Pienta; Richard G A B Sewalt; Arie P Otte; Mark A Rubin; Arul M Chinnaiyan
Journal:  Nature       Date:  2002-10-10       Impact factor: 49.962

Review 6.  DNA methylation of nuclear receptor genes--possible role in malignancy.

Authors:  J Berger; G Daxenbichler
Journal:  J Steroid Biochem Mol Biol       Date:  2002-01       Impact factor: 4.292

7.  Down regulation of estrogen receptor expression is an early event in human papillomavirus infected cervical dysplasia.

Authors:  R L M Bekkers; I A M van der Avoort; W J G Melchers; J Bulten; P C M de Wilde; L F A G Massuger
Journal:  Eur J Gynaecol Oncol       Date:  2005       Impact factor: 0.196

Review 8.  Aging, methylation and cancer.

Authors:  N Ahuja; J P Issa
Journal:  Histol Histopathol       Date:  2000-07       Impact factor: 2.303

9.  Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical cell specimens.

Authors:  K Husnjak; M Grce; L Magdić; K Pavelić
Journal:  J Virol Methods       Date:  2000-08       Impact factor: 2.014

10.  EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells.

Authors:  Celina G Kleer; Qi Cao; Sooryanarayana Varambally; Ronglai Shen; Ichiro Ota; Scott A Tomlins; Debashis Ghosh; Richard G A B Sewalt; Arie P Otte; Daniel F Hayes; Michael S Sabel; Donna Livant; Stephen J Weiss; Mark A Rubin; Arul M Chinnaiyan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-19       Impact factor: 11.205

View more
  33 in total

1.  The inhibitor of Ca(2+)-dependent K+ channels TRAM-34 blocks growth of hepatocellular carcinoma cells via downregulation of estrogen receptor alpha mRNA and nuclear factor-kappaB.

Authors:  Christian Freise; Martin Ruehl; Daniel Seehofer; Joachim Hoyer; Rajan Somasundaram
Journal:  Invest New Drugs       Date:  2012-10-02       Impact factor: 3.850

2.  Epithelial estrogen receptor 1 intrinsically mediates squamous differentiation in the mouse vagina.

Authors:  Shinichi Miyagawa; Taisen Iguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-05       Impact factor: 11.205

3.  Decorin causes autophagy in endothelial cells via Peg3.

Authors:  Simone Buraschi; Thomas Neill; Atul Goyal; Chiara Poluzzi; James Smythies; Rick T Owens; Liliana Schaefer; Annabel Torres; Renato V Iozzo
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-24       Impact factor: 11.205

4.  Targeting female hormone receptors as cervical cancer therapy.

Authors:  Sang-Hyuk Chung
Journal:  Trends Endocrinol Metab       Date:  2015-07-09       Impact factor: 12.015

5.  In search of novel drug target sites on estrogen receptors using RNA aptamers.

Authors:  Daiying Xu; Vamsee-Krishna Chatakonda; Antonis Kourtidis; Douglas S Conklin; Hua Shi
Journal:  Nucleic Acid Ther       Date:  2014-03-03       Impact factor: 5.486

6.  Requirement for stromal estrogen receptor alpha in cervical neoplasia.

Authors:  Sang-Hyuk Chung; Myeong Kyun Shin; Kenneth S Korach; Paul F Lambert
Journal:  Horm Cancer       Date:  2012-10-13       Impact factor: 3.869

7.  Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling.

Authors:  Johan A den Boon; Dohun Pyeon; Sophia S Wang; Mark Horswill; Mark Schiffman; Mark Sherman; Rosemary E Zuna; Zhishi Wang; Stephen M Hewitt; Rachel Pearson; Meghan Schott; Lisa Chung; Qiuling He; Paul Lambert; Joan Walker; Michael A Newton; Nicolas Wentzensen; Paul Ahlquist
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-08       Impact factor: 11.205

8.  The cervical malignant cells display a down regulation of ER-α but retain the ER-β expression.

Authors:  Ricardo López-Romero; Efraín Garrido-Guerrero; Angélica Rangel-López; Leticia Manuel-Apolinar; Patricia Piña-Sánchez; Minerva Lazos-Ochoa; Alejandra Mantilla-Morales; Cindy Bandala; Mauricio Salcedo
Journal:  Int J Clin Exp Pathol       Date:  2013-07-15

9.  Requirement of estrogen receptor alpha DNA-binding domain for HPV oncogene-induced cervical carcinogenesis in mice.

Authors:  Jieun Son; Jung Wook Park; Paul F Lambert; Sang-Hyuk Chung
Journal:  Carcinogenesis       Date:  2013-10-22       Impact factor: 4.944

10.  SERMs suppresses the growth of ERα positive cervical cancer xenografts through predominant inhibition of extra-nuclear ERα expression.

Authors:  Balaji Ramachandran; Kanchan Murhekar; Shirley Sundersingh
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.